Funny forum

[HairBane]

You can find their key statistics here: http://finance.yahoo.com/q/ks?s=SMDI+Key+Statistics

They're out of cash and burn 8M/year.

Yeah these two guys, that's interesting for sure. I didn't get where they came from though, but it seems they're just shareholders of that cage fighting company ?

Hmm I'm not sure. Hopefully they're not just making a grab for some easy funding from baldies because they're broke. I doubt that's the case.

This paragraph:

"Histogen's technology platform opens a spectrum of potential product opportunities in both aesthetics and therapeutics, an ideal fit with our vision for Restorgenex," said Sol J. Barer, Ph.D., who will assume the position of Chairman of the Board of Restorgenex effective November 1, 2013. "The expertise of the Histogen team in developing regenerative products from concept to market, along with the success Histogen has already found in skincare partnering, will add significant value to our Company."

Seems to indicate he's more than just a shareholder, maybe they were brought on by the MMA company and given some percentage too?

This:
"It is an honor to be working with biotechnology visionaries Dr. Sol Barer and Isaac Blech, and to have them recognize the promise of Histogen's products is a true testament to the unique and exciting nature of our technology."
Also sounds positive.

[Thinning87]

They're probably two investors who have had some degree of success in their industry and who believe in histogen. The rest is all for accounting purposes.

I'm just kind if worried about marketing and sales channels honestly, I was hoping for a big pharma company to come in and provide infrastructure for development, trained sales force, and a ton of cash. Replicel style. I am however faithful that they know what they're doing and don't need us to tell them,especially with our limited knowledge.

[lothar99]

Merging with Histogen doesn't seem to be some random acquire. Last month they also announced they are merging with Canterbury Laboratories, LLC and Hygeia Therapeutics, Inc.

One of the things Hygeia was developing a non-steroidal topical anti-androgen that never got into trials, I think. (http://www.baldtruthtalk.com/showthread.php?t=1708)

"Stratus, which will be renamed Restorgenex Corporation, plans to create a world-class cosmeceutical and pharmaceutical company in the large and expanding field of dermatology and restorative medicine. The merger agreement was approved by the board of directors of all companies and is expected to close following the satisfaction of customary closing conditions including the completion of the audit of Canterbury and Hygeia. Upon the closing, Stratus will acquire the exclusive license for 24 patent-protected compounds from Yale University. These unique compounds address hormonal aging and are scientifically validated to improve the appearance of skin and hair. Upon the closing, Restorgenex Corporation plans to build an anti-aging skincare brand for women over forty-five."

[whateva]

Stratus is just a shell company, the MMA ops will be discontinued. Yes, they're "broke" - they'll use the public stock as a financing vehicle for Histogen and Hygeia.

[Desmond84]

Holy! Histogen & Hygeia are merging together!!! That's one for the books

Gail just got her hands on the patent for a topical anti-androgen similar to CB-03-01....

Let the race begin

[Desmond84]

Isn't it amazing how we were talking about Hygeia just yesterday! LOL

Hygeia Pharmaceuticals: seems to have gone bust! All their operation was halted in 2010. Sad thing is they had a topical non-steroidal anti-androgen in the pipeline, which may have been better than CB-03-01

Let's hope this lets the ball rolling towards an actual marketable product because God knows how tired we are of waiting!

- Fingers crossed

[moore]

which may have been better than CB-03-01

Better in which sense, receptor affinity?

PS one question not in a particular thread.

Is there any chanche to think about a delivery method, through injection, which involves the needle directly injecting in the follicles?

Just wondering how a compound that you inject in the scalp, NEAR a follicle, is supposed to know where to exert its function. Every video I saw involving scalp ijections (es. Replicel) seems to feature the neele entering at random spot. Thanks!!!

[Thinning87]

Better in which sense, receptor affinity?

PS one question not in a particular thread.

Is there any chanche to think about a delivery method, through injection, which involves the needle directly injecting in the follicles?

Just wondering how a compound that you inject in the scalp, NEAR a follicle, is supposed to know where to exert its function. Every video I saw involving scalp ijections (es. Replicel) seems to feature the neele entering at random spot. Thanks!!!

Open new thread

[Pentarou]

Isn't this all rather worrying, if Histogen is involved with a reverse merger? They can't have been able to get the funding they needed via regular means, and may explain why they are so behind on trials.

[lothar99]

Isn't this all rather worrying, if Histogen is involved with a reverse merger? They can't have been able to get the funding they needed via regular means, and may explain why they are so behind on trials.

Could be good, could be bad. Hopefully they weren't acquired merely for their patents...

[UK_]

They're going to beat mpb into submission i guess...

Sorry im late, but LOL.

[Desmond84]

Better in which sense, receptor affinity?

PS one question not in a particular thread.

Is there any chance to think about a delivery method, through injection, which involves the needle directly injecting in the follicles?

Just wondering how a compound that you inject in the scalp, NEAR a follicle, is supposed to know where to exert its function. Every video I saw involving scalp ijections (es. Replicel) seems to feature the neele entering at random spot. Thanks!!!

The Hygeia anti-androgen breaks down by enzymes in your skin quite rapidly hence the lack of systemic side effects Its advantage over CB-03-01 is the fact that it is non-steroidal meaning lower risk of skin atrophy due to prolonged use!

With regards to injecting these compounds, since they don't have systemic activity (due to enzymatic breakdown) you would need to inject it over 500 times to cover your entire MPB zone and that is TWICE A WEEK. I'm sure non of us are that desperate! or maybe we are LOL

[TravisB]

With regards to injecting these compounds, since they don't have systemic activity (due to enzymatic breakdown) you would need to inject it over 500 times to cover your entire MPB zone and that is TWICE A WEEK. I'm sure non of us are that desperate! or maybe we are LOL

So in other words it's useless.

IMO CB-03-01 is our only chance to get something better than Propecia before 2018

[HairBane]

So in other words it's useless.

IMO CB-03-01 is our only chance to get something better than Propecia before 2018

Read it again

[UK_]

A few months ago I emailed Gail and she told me she was attending an event that would be full of investors - its clear she did some networking and these guys are seeing potential in Histogen and have invested - now remember back when Gail sent my friend an email saying extra funds will help speed the product to the market - Gail now has those funds via these new investors so HSC will be here faster than anything else being developed!!!!!!